MedTrace Logo

Validation of a Frailty Self Assessment Tool

NCT04085432 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5134

Last updated 2020-09-18

No results posted yet for this study

Summary

The number of elderly is increasing throughout of the world. Aging is associated with increasing diseases that may be preventable. Over the last decades, frailty has emerged as one of the major risk factors for loss of autonomy. Frailty can be reversed through appropriate interventions particularly when they are implemented early. Therefore, early detection of frailty is a major objective. The goal of this study is to identify elderly subjects aged 70 years and over at the early stage of frailty by using a self administered questionnaire sent to the participant by mail. The results of the self assessment will be compared to the Fried criteria collected by a clinical examination conducted by a healthcare Professional blinded to the self assessment results.

Conditions

Interventions

OTHER

Self administered questionnaire and Clinical evaluation

Self administered questionnaire and clinical evaluation

Sponsors & Collaborators

  • International Longevity Centre France

    lead OTHER

Principal Investigators

  • Françoise FORETTE, MD · ILC France and Universite Paris Descartes

Eligibility

Min Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-10-03
Primary Completion
2020-08-19
Completion
2020-08-19

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04085432 on ClinicalTrials.gov